What Is BioCardia, Inc. (BCDA) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, BioCardia, Inc.'s intrinsic value is estimated at a composite fair value of $0.43. Trading at $0.88, the stock is approaching fair value or slight overvaluation (implied return of -51.1%), as 6 of 9 models suggest limited further upside. Model dispersion is worth noting: Dynamic NAV targets $1.15 (+30.9%), versus ML-RIV at $0.02 (-97.5%). This +128.4% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About BCDA?
9 of 13 models are currently active for BCDA. Of these, 2 models suggest upside while 7 models suggest overvaluation. The Bayesian DCF estimates BCDA's intrinsic value at $0.35, implying -60.0% downside from the current price. See which stocks rank higher →
How Does BCDA Rank in Biological Products, (No Diagnostic Substances)?
Among 134 Biological Products, (No Diagnostic Substances) stocks, BCDA ranks #107 by Quality of Company score. CirclFi's QOC score of 4.3/10 evaluates 32 fundamental signals. A score of 4.3 reflects mixed fundamentals.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
BioCardia, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is BCDA a Value Trap?
CirclFi's Value Trap algorithm assigns BCDA a score of 52/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for BioCardia, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, BioCardia, Inc. scores 4.3 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +128.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every BCDA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across BCDA's 9 active models, average confidence is 19%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad